EVESTEAD (Class 5)
#4362830
Application Number:4362830
Status: DRAFT
Class:5
Applicant:STEADFAST MEDISHIELD PRIVATE LIMITED
Filing Date:Fri, 29 Nov 2019
In Progress
Is this your trademark application?
"EVESTEAD" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.
Trademark Information
| Trademark | EVESTEAD |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 4362830 |
| Nature/Scope of business | Everolimus is the 40 - 0 - (2- hydroxyethyl) derivative of sirolimus and works as an inhibitors of mammalian target of rapamycin (Motor) itis currently used as an immunosuppressant to prevent rejection of organ transplants and in the treatment of organ transplants and in the treatment of renal cell cancer and other tumors. The brand name EVESTEAD is derived from generic from Everolinus from the Company Steadfast Medishield. |
| Publication | In Journal No. 1934 |
| Status | DRAFT |
| Applicant: | STEADFAST MEDISHIELD PRIVATE LIMITED |
| Applicant Address | 106, First Floor Anupam Plaza-I, LSC Ghazipur, Delhi-11092 Proposed to be used |
| Jurisdiction | DELHI |
| Agent | MR. KAMAL AHUJA |
| Agent Address | C-119, FIRST FLOOR, LAJPAT NAGAR, PART-II, NEW DELHI 110024 |
Frequently Asked Questions
What is the status of trademark EVESTEAD? ▾
The trademark application number 4362830 is currently marked as "DRAFT" in the official trademark registry.
Who is the owner of trademark EVESTEAD? ▾
The trademark application number 4362830 is owned by STEADFAST MEDISHIELD PRIVATE LIMITED.
Which class does trademark EVESTEAD belong to? ▾
Trademark application number 4362830 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 4362830? ▾
The trademark agent associated with application number 4362830 is MR. KAMAL AHUJA.
Was trademark EVESTEAD published in the journal? ▾
Yes, trademark application number 4362830 was published in Journal No. 1934.
What is trademark EVESTEAD? ▾
Trademark application number 4362830 relates to "Everolimus is the 40 - 0 - (2- hydroxyethyl) derivative of sirolimus and works as an inhibitors of mammalian target of rapamycin (Motor) itis currently used as an immunosuppressant to prevent rejection of organ transplants and in the treatment of organ transplants and in the treatment of renal cell cancer and other tumors. The brand name EVESTEAD is derived from generic from Everolinus from the Company Steadfast Medishield.".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified